120 related articles for article (PubMed ID: 21676068)
1. Wireless ambulatory pH studies: manometric or endoscopic guidance?
Nusrat S; Roy PM; Bielefeldt K
Dis Esophagus; 2012 Jan; 25(1):26-32. PubMed ID: 21676068
[TBL] [Abstract][Full Text] [Related]
2. 24 Versus 48-hour bravo pH monitoring.
Chander B; Hanley-Williams N; Deng Y; Sheth A
J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
4. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
Doma S; Paladugu S; Parkman HP; Friedenberg FK
Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
[TBL] [Abstract][Full Text] [Related]
5. Wireless esophageal pH monitoring: new technique means new questions.
Bhat YM; McGrath KM; Bielefeldt K
J Clin Gastroenterol; 2006 Feb; 40(2):116-21. PubMed ID: 16394871
[TBL] [Abstract][Full Text] [Related]
6. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?
Belafsky PC; Godin DA; Garcia JC; Rahim N
Laryngoscope; 2005 Jun; 115(6):1109-13. PubMed ID: 15933532
[TBL] [Abstract][Full Text] [Related]
7. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
Domingues GR; Moraes-Filho JP; Domingues AG
Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
[TBL] [Abstract][Full Text] [Related]
8. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
9. Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease.
Ayazi S; Hagen JA; Zehetner J; Banki F; Augustin F; Ayazi A; DeMeester SR; Oh DS; Sohn HJ; Lipham JC; DeMeester TR
Surg Endosc; 2011 Jul; 25(7):2219-23. PubMed ID: 21359906
[TBL] [Abstract][Full Text] [Related]
10. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Loughney T; Maydonovitch CL; Wong RK
Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
[TBL] [Abstract][Full Text] [Related]
11. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
12. Acid reflux immediately above the squamocolumnar junction and in the distal esophagus: simultaneous pH monitoring using the wireless capsule pH system.
Wenner J; Johnsson F; Johansson J; Oberg S
Am J Gastroenterol; 2006 Aug; 101(8):1734-41. PubMed ID: 16817841
[TBL] [Abstract][Full Text] [Related]
13. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.
Decktor DL; Krawet SH; Rodriguez SL; Robinson M; Castell DO
Am J Gastroenterol; 1996 Jun; 91(6):1162-6. PubMed ID: 8651164
[TBL] [Abstract][Full Text] [Related]
14. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
[TBL] [Abstract][Full Text] [Related]
15. Differences in manometry and 24-H ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease.
Kasapidis P; Xynos E; Mantides A; Chrysos E; Demonakou M; Nikolopoulos N; Vassilakis JS
Am J Gastroenterol; 1993 Nov; 88(11):1893-9. PubMed ID: 8237938
[TBL] [Abstract][Full Text] [Related]
16. Wireless pH recording immediately above the squamocolumnar junction improves the diagnostic performance of esophageal pH studies.
Wenner J; Hall M; Höglund P; Johansson J; Johnsson F; Oberg S
Am J Gastroenterol; 2008 Dec; 103(12):2977-85. PubMed ID: 18786112
[TBL] [Abstract][Full Text] [Related]
17. Continuous 48-Hour Wireless Esophageal pH Monitoring in Children: Comparison Between Days 1 and 2.
Ravi A; Gunasekaran T; Berman J
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):87-9. PubMed ID: 26196198
[TBL] [Abstract][Full Text] [Related]
18. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
[TBL] [Abstract][Full Text] [Related]
19. Bravo (wireless) ambulatory esophageal pH monitoring: how do day 1 and day 2 results compare?
Bechtold ML; Holly JS; Thaler K; Marshall JB
World J Gastroenterol; 2007 Aug; 13(30):4091-5. PubMed ID: 17696227
[TBL] [Abstract][Full Text] [Related]
20. Sedation and Afternoon Placement of the 48-Hour Wireless Ambulatory pH Capsule Results in More Reflux on the First Day.
Patel R; Chae S; Kumar A; Richter JE
J Clin Gastroenterol; 2017 Aug; 51(7):594-598. PubMed ID: 27548735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]